Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487394 · ClinicalTrials.gov registry record
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- 9
- Enrollment target
NCT02487394 is a clinical trial that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 9 participants.
The verdict
NCT02487394 was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of the study is to better understand proteomics of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, we propose is to use discovery proteomics and techniques to identify protein expression signatures. Subjects who complete Phase I are eligible, but not required, to enroll in Phase II. In Phase II, we propose to establish and validate the predictive value of protein signatures for treatment responses using inhaled corticosteroids.
Interventions
- PROCEDURE Exhaled Breath Condensate (EBC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02487394
The ClinicalTrials.gov registry entry for NCT02487394 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exhaled Breath Condensate (EBC) is the first listed.
NCT02487394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02487394 about?
NCT02487394 is a clinical study titled "Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma". The purpose of the study is to better understand proteomics of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, we propose is to use discovery proteomics and techniques to identify protein expression signatures. Subjects who complete Phas...
What is the current status of trial NCT02487394?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02487394?
The interventions under investigation include: Exhaled Breath Condensate (EBC) (PROCEDURE).
Who is sponsoring clinical trial NCT02487394?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.